Recently, Insilico Medicine, a generative AI-driven clinical-stage biotechnology company, announced that it has piloted the launch of an automated AI business development platform—Automated Partnering System. Based on a pre-integrated database, the platform can directly handle preliminary due diligence inquiries, transforming cumbersome manual communication processes into an automated closed loop.
